Kwality Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	398.45	237.96	193.72	1,200	151.46
Depreciation & Amortization	182.9	195.59	149.58	106.91	64.93
Other Amortization	-	-	-	-	0.35
Loss (Gain) From Sale of Assets	-0.28	-0.02	-0.54	-	0.2
Other Operating Activities	82.47	230.67	60.91	30.91	22.88
Change in Accounts Receivable	-399.2	-426.91	-25.64	-	-53.8
Change in Inventory	-50.78	27.35	-329.54	-359.96	50.52
Change in Accounts Payable	114.76	91.25	6.78	-	32.49
Change in Other Net Operating Assets	198.87	73.95	358.55	-371.81	-1.98
Operating Cash Flow	527.18	429.83	413.82	605.97	267.05
Operating Cash Flow Growth	22.65%	3.87%	-31.71%	126.91%	333.20%
Capital Expenditures	-232.93	-298.41	-476.73	-551.52	-234
Sale of Property, Plant & Equipment	0.76	41.12	18.63	-	1.44
Sale (Purchase) of Intangibles	-17.1	-	-	-	-
Investment in Securities	-	-	-	-	-1.29
Other Investing Activities	-35.89	-6.67	-26.3	-77.75	1.81
Investing Cash Flow	-285.15	-263.97	-484.41	-629.28	-232.03
Short-Term Debt Issued	-	-	-	-	3,579
Long-Term Debt Issued	87.94	40.56	115.48	85.74	151.68
Total Debt Issued	87.94	40.56	115.48	85.74	3,731
Short-Term Debt Repaid	-	-	-	-	-3,646
Long-Term Debt Repaid	-133.57	-112.59	-45.34	-	-50.92
Total Debt Repaid	-133.57	-112.59	-45.34	-	-3,697
Net Debt Issued (Repaid)	-45.62	-72.03	70.14	85.74	34.39
Other Financing Activities	-98.78	-101.95	-60.2	-29.17	-26.72
Financing Cash Flow	-144.4	-173.98	9.94	56.57	7.67
Miscellaneous Cash Flow Adjustments	0	-0	-	0	-
Net Cash Flow	97.62	-8.12	-60.65	33.26	42.7
Free Cash Flow	294.25	131.42	-62.92	54.45	33.06
Free Cash Flow Growth	123.91%	-	-	64.69%	-
Free Cash Flow Margin	7.95%	4.28%	-2.51%	1.19%	1.26%
Free Cash Flow Per Share	28.36	12.66	-6.06	5.25	3.19
Cash Interest Paid	98.78	101.95	60.2	29.17	26.72
Cash Income Tax Paid	157.9	13	61.56	413.54	63.84
Levered Free Cash Flow	-64.32	-130.94	-258.69	-225.56	-28.71
Unlevered Free Cash Flow	-2.58	-66.02	-221.06	-207.33	-11.99
Change in Working Capital	-136.35	-234.36	10.14	-731.77	27.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.